Synthomer PLC Given “Buy” Rating at Canaccord Genuity (SYNT)
Synthomer PLC (LON:SYNT)‘s stock had its “buy” rating reiterated by equities research analysts at Canaccord Genuity in a research note issued to investors on Monday. They currently have a GBX 283 ($4.75) target price on the stock. Canaccord Genuity’s target price suggests a potential upside of 36.12% from the stock’s previous close.
Shares of Synthomer PLC (LON:SYNT) traded up 8.32% on Monday, hitting GBX 225.20. 467,632 shares of the company’s stock traded hands. Synthomer PLC has a 52 week low of GBX 194.90 and a 52 week high of GBX 302.08. The stock has a 50-day moving average of GBX 272.9 and a 200-day moving average of GBX 255.1.
The company also recently announced a dividend, which is scheduled for Thursday, November 6th. Stockholders of record on Thursday, October 9th will be paid a dividend of GBX 3 ($0.05) per share. This represents a dividend yield of 1.31%. The ex-dividend date is Thursday, October 9th.
Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Synthomer PLC in a research note on Monday, July 21st. They now have a GBX 225 ($3.77) price target on the stock. Separately, analysts at Numis Securities Ltd upgraded shares of Synthomer PLC to a “buy” rating in a research note on Monday, July 14th. They now have a GBX 300 ($5.03) price target on the stock. Finally, analysts at Deutsche Bank cut their price target on shares of Synthomer PLC from GBX 245 ($4.11) to GBX 225 ($3.77) in a research note on Monday, July 14th. They now have a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of GBX 263.73 ($4.42).
Synthomer PLC is a specialty chemical Company. It is a producer of aqueous polymers. It derives its revenues from the sale of polymer products derived from petrochemical monomers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.